Options Trading News

September 25, 2013  Wed 7:33 AM CT


Earnings, Sales, Guidance Strong

Ascena Retail earned $0.34 a share in the fourth quarter, crushing analysts' estimates for profit of $0.21. Sales of $1.20 billion also beat the $1.17 billion consensus number, and guidance was strong. ASNA surges 14 percent before the opening bell on my tradeMONSTER platform.

Copart Falls on Weak Results

Copart reported quarterly profit of just $0.33 a share, missing the $0.40 average analyst estimate. The company also announced that it has abandoned efforts to become a real-estate investment trust. CPRT drops 10 percent in the premarket.

A Lifeline for Oncothyreon

Oncothyreon cratered in December on weak trial data for its L-BLP25 cancer compound, but is getting a major shot in the arm today after Germany's Merck KGaA decided to continue clinical development. ONTY rockets 25 percent on the news!

Share this article with your friends

Related Stories


How traders are staying with Ascena

September 9, 2015

The retailer company is still down some 67 percent on the year but has rebounded since plunging with the broader market last month.



The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

Options Academy: More on the Covered Call Strategy

Last week, we talked about the Covered Call and the misconceptions that surround it. We spoke about how an investor must realize that the Covered Call is actually a premium collection strategy and not so much a directional one. If an investor can grasp this idea, the investor stands to do a heck of a lot better in the strategy than they currently do.

View more education articles »